Abstract:Background Yttrium‐90 (90Y ) represents the primary radioisotope used in radioembolization procedures, while holmium‐166 (166Ho ) is hypothesized to serve as a viable substitute for 90Y due to its comparable therapeutic potential and improved quantitative imaging. Voxel‐based dosimetry for these radioisotopes relies on activity images obtained through PET or SPECT and dosimetry methods, including the voxel S‐value (VSV) and the local deposition method (LDM). However, the evaluation of the accuracy of absorbed dose calculations has been limited by the use of non‐ideal reference standards and investigations restricted to the liver. The objective of this study was to expand upon these dosimetry characterizations by investigating the impact of image resolutions, voxel sizes, target volumes, and tissue materials on the accuracy of 90Y and 166Ho dosimetry techniques. Methods A specialized radiopharmaceutical dosimetry software called reDoseMC was developed using the Geant4 Monte Carlo toolkit and validated by benchmarking the generated 90Y kernels with published data. The decay spectra of both 90Y and 166Ho were also compared. Multiple VSV kernels were generated for the liver, lungs, soft tissue, and bone for isotropic voxel sizes of 1 mm, 2 mm, and 4 mm. Three theoretical phantom setups were created with 20 or 40 mm activity and mass density inserts for the same three voxel sizes. To replicate the limited spatial resolutions present in PET and SPECT images, image resolutions were modeled using a 3D Gaussian kernel with a Full Width at Half Maximum (FWHM) ranging from 0 to 16 mm and with no added noise. The VSV and LDM dosimetry methods were evaluated by characterizing their respective kernels and analyzing their absorbed dose estimates calculated on theoretical phantoms. The ground truth for these estimations was calculated using reDoseMC. Results The decay spectra obtained through reDoseMC showed less than a 1% difference when compared to previously published experimental data for energies below 1.9 MeV in the case of 90Y and less than 1% for energies below 1.5 MeV for 166Ho . Additionally, the validation kernels for 90Y VSV exhibited results similar to those found in published Monte Carlo codes, with source dose depositions having less than a 3% error margin. Resolution thresholds (FWHMthreshs ), defined as resolutions that resulted in similar dose estimates between the LDM and VSV methods, were observed for 90Y . They were 1.5 mm for bone, 2.5 mm for soft tissue and liver, and 8.5 mm for lungs. For 166Ho , the accuracy of absorbed dose deposition was found to be dependent on the contributions of absorbed dose from photons. Volume errors due to variations in voxel size impacted the final dose estimates. Larger target volumes yielded more accurate mean doses than smaller volumes. For both radioisotopes, the radial dose profiles for the VSV and LDM approximated but never matched the reference standard. Conclusions reDoseMC was developed and validated for radiopharmaceutical dosimetry. The accuracy of voxel‐based dosimetry was found to vary widely with changes in image resolutions, voxel sizes, chosen target volumes, and tissue material; hence, the standardization of dosimetry protocols was found to be of great importance for comparable dosimetry analysis.

Phantom study for 90 Y liver radioembolization dosimetry with a long axial field-of-view PET/CT

Phantom study for 90Y post-treatment dosimetry with a long axial field-of-view PET/CT

Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom

PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study

A comparison of methods for in vivo activity and absorbed dose quantification with PET/CT following yttrium‐90 radioembolization

An international phantom study of inter-site variability in Technetium-99m image quantification: analyses from the TARGET radioembolization study

Monte Carlo Simulation of Liver Dosimetry with Yttrium-90 Radionuclide Using Gate: 3D Phantom

Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model.

Pre-treatment dosimetry in90Y-SIRT: Is it possible to optimise SPECT reconstruction parameters and calculation methods for accurate dosimetry?

Yttrium-90 TOF-PET based EUD predicts response post liver radioembolizations using standard manufacturer reconstruction parameters

Quantification performance of silicon photomultiplier-based PET for small 18F-, 68Ga- and 124I-avid lesions in the context of radionuclide therapy planning

Quantitative evaluation of 90Y‐PET/CT and 90Y‐SPECT/CT‐based dosimetry following Yttrium‐90 radioembolization

Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer

Measure of 90Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison 99mTc-MAA SPECT/CT dosimetry

Characterizing the voxel‐based approaches in radioembolization dosimetry with reDoseMC

Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC

Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation

Utilizing 3D Slicer to incorporate tomographic images into GATE Monte Carlo simulation for personalized dosimetry in yttrium-90 radioembolization

Translating contrast enhanced computed tomography images to liver radioembolization dose distribution for more comprehensively indicating patients

A Technical Perspective on Same-Day Radioembolization

Utility of pre-procedural [99mTc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of 90Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [99mTc]TcMAA-based Segmentation